| Product Code: ETC12626215 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Singapore Oncology Anti-Cancer Drugs Market Overview |
3.1 Singapore Country Macro Economic Indicators |
3.2 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Singapore Oncology Anti-Cancer Drugs Market - Industry Life Cycle |
3.4 Singapore Oncology Anti-Cancer Drugs Market - Porter's Five Forces |
3.5 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.9 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Singapore Oncology Anti-Cancer Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Singapore |
4.2.2 Advancements in oncology research leading to the development of innovative anti-cancer drugs |
4.2.3 Growing healthcare infrastructure and investment in oncology treatment facilities |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval processes for new anti-cancer drugs |
4.3.2 High cost associated with oncology treatments and drugs |
4.3.3 Competition from generic anti-cancer drugs impacting market prices |
5 Singapore Oncology Anti-Cancer Drugs Market Trends |
6 Singapore Oncology Anti-Cancer Drugs Market, By Types |
6.1 Singapore Oncology Anti-Cancer Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.1.4 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.1.5 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Hormone Therapy, 2021 - 2031F |
6.1.6 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.1.7 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Precision Medicine, 2021 - 2031F |
6.2 Singapore Oncology Anti-Cancer Drugs Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Lung Cancer, 2021 - 2031F |
6.2.3 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.2.4 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Prostate Cancer, 2021 - 2031F |
6.2.5 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.2.6 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Leukemia, 2021 - 2031F |
6.3 Singapore Oncology Anti-Cancer Drugs Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.3 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.3.4 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.3.5 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Topical, 2021 - 2031F |
6.3.6 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.4 Singapore Oncology Anti-Cancer Drugs Market, By Therapy Type |
6.4.1 Overview and Analysis |
6.4.2 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.4.3 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.4.4 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Hormone Therapy, 2021 - 2031F |
6.4.5 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.4.6 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.5 Singapore Oncology Anti-Cancer Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.5.3 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5.4 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.5.5 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Specialty Pharmacies, 2021 - 2031F |
6.5.6 Singapore Oncology Anti-Cancer Drugs Market Revenues & Volume, By Mail Order Pharmacies, 2021 - 2031F |
7 Singapore Oncology Anti-Cancer Drugs Market Import-Export Trade Statistics |
7.1 Singapore Oncology Anti-Cancer Drugs Market Export to Major Countries |
7.2 Singapore Oncology Anti-Cancer Drugs Market Imports from Major Countries |
8 Singapore Oncology Anti-Cancer Drugs Market Key Performance Indicators |
8.1 Patient survival rates and improvement in quality of life post-treatment |
8.2 Adoption rate of new anti-cancer drugs in clinical settings |
8.3 Number of clinical trials conducted for oncology drugs in Singapore |
8.4 Rate of approval for new anti-cancer drugs by regulatory authorities |
8.5 Investment in research and development for oncology drugs in Singapore |
9 Singapore Oncology Anti-Cancer Drugs Market - Opportunity Assessment |
9.1 Singapore Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Singapore Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 Singapore Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Singapore Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.5 Singapore Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Singapore Oncology Anti-Cancer Drugs Market - Competitive Landscape |
10.1 Singapore Oncology Anti-Cancer Drugs Market Revenue Share, By Companies, 2024 |
10.2 Singapore Oncology Anti-Cancer Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here